Brief: United Laboratories International Says UBT251 Injection Obtained Acceptance Notices By China NMPA
16/06/2023 15:44
June 16 (Reuters) - United Laboratories International
Holdings Ltd 3933.HK :
* UBT251 INJECTION OBTAINED ACCEPTANCE AND PAYMENT NOTICES
BY
CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Source text for Eikon: ID:
Further company coverage: 3933.HK
Recent news on United Laboratories International Holdings
See all newsBrief: United Laboratories International Receives Milestone Payment From Novo
Brief: United Laboratories International Says NMPA Accepts Insulin Degludec And Liraglutide Injection Marketing Registration Application
Brief: United Laboratories International Posts HY Profit Attributable RMB 347.6 Million
China's United Laboratories half-year profit drops 82%
Brief: United Laboratories International Expects HY Net Profit RMB 340 Million